You are here

KRAS inhibitors

Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS

BioSpace

Fri, 04/5/24 - 11:42 am

clinical trials

KRAS inhibitors

non-small lung cancer

Frontier gets $80M, Galapagos’ backing to make a better KRAS drug

BioPharma Dive

Thu, 02/22/24 - 11:18 pm

Frontier Medicines

KRAS inhibitors

Jazz buys KRAS inhibitors from Redx in $880m deal

Pharmaphorum

Wed, 02/7/24 - 11:18 am

KRAS inhibitors

Merck's early KRAS data suggest combination-friendly safety

Fierce Biotech

Mon, 10/23/23 - 10:30 am

KRAS inhibitors

Amgen's Lumakras flunks FDA expert meeting, but market withdrawal looks unlikely for now

Fierce Pharma

Thu, 10/5/23 - 09:13 pm

KRAS inhibitors

Sanofi weighs Mirati buy as KRAS cancer drug battle enters new phase

Fierce Pharma

Thu, 10/5/23 - 09:10 pm

Mirati Therapeutics

KRAS inhibitors

Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors

BioSpace

Thu, 08/24/23 - 11:50 am

KRAS inhibitors

clinical trials

KRAS crisis? FDA will gather advisers to weigh full approval for Amgen's Lumakras

Fierce Pharma

Mon, 08/21/23 - 06:56 pm

KRAS inhibitors

Mirati CEO Steps Down After Going Toe-to-Toe with Amgen in KRAS

BioSpace

Wed, 08/9/23 - 11:55 am

Mirati Therapeutics

KRAS inhibitors

In fast-growing KRAS field, this oncology veteran is chasing the toughest cancer targets

Pharma Voice

Tue, 07/25/23 - 10:07 am

Affini-T Therapeutics

KRAS inhibitors

AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'

Fierce Biotech

Tue, 04/18/23 - 10:18 pm

Mirati Therapeutics

KRAS inhibitors

ESMO 2022 movers – KRAS backfires

EP Vantage

Thu, 09/15/22 - 10:12 am

KRAS inhibitors

Relay Therapeutics

Clovis Oncology

Ayala Pharmaceuticals

Mirati Therapeutics

ESMO: Amgen's Lumakras confirmatory lung cancer data are here, fanning KRAS battle flames

Fierce Pharma

Sun, 09/11/22 - 11:07 pm

KRAS inhibitors

Genentech pays Relay $75M for cancer drug, plans KRAS combo

Fierce Biotech

Mon, 12/14/20 - 11:07 am

Relay Therapeutics

KRAS inhibitors

Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort

Fierce Biotech

Thu, 07/30/20 - 11:11 am

KRAS inhibitors

Researchers Develop New Class of Lung Cancer Drugs

BioSpace

Thu, 09/19/19 - 12:15 pm

KRAS inhibitors

Institute of Cancer Research

drug development

What could help biotech close out 2019 stronger? Analysts pick 3 events to watch

Biopharma Dive

Sat, 09/7/19 - 06:38 pm

KRAS inhibitors

PTC Therapeutics

Here's Why Mirati Therapeutics Is Surging Today

Motley Fool

Thu, 05/16/19 - 06:42 pm

Mirati Therapeutics

KRAS inhibitors